ARTICLE
13 December 2019

Guidelines On Risk Factors Under The Prospectus Regulation

EN
Elias Neocleous & Co LLC

Contributor

Elias Neocleous & Co LLC is the largest law firm in Cyprus and a leading firm in the South-East Mediterranean region, with a network of offices across Cyprus (Limassol, Nicosia, Paphos), Belgium (Brussels), Czech Republic (Prague), Romania (Budapest) and Ukraine (Kiev). A dynamic team of lawyers and legal experts deliver strategic legal solutions to clients operating in key industries across Europe, Asia, the Middle East, India, USA, South America, and China. The firm is renowned for its expertise and jurisdictional knowledge across a broad spectrum of practice areas, spanning all major transactional and market disciplines, while also managing the largest and most challenging cross-border assignments. It is a premier practice of choice for leading Cypriot banks and financial institutions, preeminent foreign commercial and development banks, multinational corporations, global technology firms, international law firms, private equity funds, credit agencies, and asset managers.
CySEC has issued Circular C.344 (available in English here) addressed to those persons who are responsible for the preparation and issuing of an investment prospectus.
Cyprus Corporate/Commercial Law

CySEC has issued Circular C.344 (available in English here) addressed to those persons who are   responsible for the preparation and issuing of an investment prospectus. Circular C.344 adopts the European Securities and Markets Authority (ESMA) guidelines, on risk factors under the Prospectus Regulation {Regulation (EU) 2017/1129 of the European Parliament and of the Council, of 14 June 2017, on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC 'Regulation (EC) 2017/1129')}.

These guidelines are addressed to the Competent Authorities designated by each Member State in accordance with Article 31 of the Regulation (EU) 2017/1129 and apply from 4 December 2019. CySEC is the Competent Authority for Cyprus. It should be noted that, in order to expedite the approval process,  persons responsible for creating a prospectus should also consider these guidelines when preparing the relevant material for submission to CySEC.

As stated in Regulation (EC) 2017/1129, the primary purpose of including risk factors in a prospectus and/or a supplement is to ensure that investors can assess the relevant risks related to their investment and can therefore make informed investment decisions in full knowledge of the facts. Consequently, the C.344 guidelines state that the risk factors to be included in a prospectus and/or supplement should be limited to those which are material and specific to the issuer and/or its securities and which are corroborated by the content of the prospectus.

The aim of the guidelines is to ensure an appropriate, focused, and more streamlined disclosure of risk factors in the prospectus. This will assist the Competent Authorities in their review of specific and material aspects of these factors and in assessing the adequateness of their presentation to potential investors.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More